Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,682 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06586593 | Neoadjuvant Immunotherapy of Operable Metastatic Melanoma in Real Life (GCC)(NEOMEL) | recruiting | — | 77 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT05714774 | Evaluation of Different Methods of Ultrasound Image Analysis for Real-time Monitoring of HIFU Prostate Cancer Treatment(ELASTO-US) | recruiting | N/A | 40 | Hospices Civils de LyonOTHER |
| 1 |
| Sep 4, 2024 |
| clinicaltrials |
| NCT06314607 | Genetic and Molecular Characterization of Nervous System Lesions(ONCONEUROTEK 2) | recruiting | — | 10,000 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Sep 4, 2024 | clinicaltrials |
| NCT04498767 | Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)(OligoRARE) | recruiting | N/A | 200 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Aug 26, 2024 | clinicaltrials |
| NCT02511288 | LIquid BIopsies in Patients Presenting Non-small Cell Lung Cancer(LIBIL) | recruiting | — | 900 | Centre Leon BerardOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT04989491 | Evaluation of the Efficacy of a Treatment by One Single Dose of Rituximab (375mg/m2 ) in the Prevention of the Epstein Barr Virus (EBV) Primary Infection and Post-transplant Lymphoproliferative Disorder in Adult EBV Seronegative Patients Who Received an EBV Seropositive Kidney Allograft(REPLY) | recruiting | Phase 4 | 120 | University Hospital, Strasbourg, FranceOTHER | 1 | Aug 19, 2024 | clinicaltrials |
| NCT06393816 | FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and Platinum(FIRST-NEC) | recruiting | Phase 2 | 80 | Centre Leon BerardOTHER | 2 | Aug 2, 2024 | clinicaltrials |
| NCT06536127 | Prospective Monocentric Study Evaluating the Circulating NK Cells Phenotype and the ImmunoScore® in Patients With Non Metastatic Rectal Cancer(IMMUNOREC) | recruiting | N/A | 100 | Institut Sainte CatherineOTHER | 1 | Aug 2, 2024 | clinicaltrials |
| NCT03966612 | Study and Monitoring of Multiple Endocrine Neoplasia Type 1(NEM) | recruiting | — | 1,600 | Centre Hospitalier Universitaire DijonOTHER | 1 | Jul 29, 2024 | clinicaltrials |
| NCT06514651 | MAQ-001 in Patients With Advanced Solid Tumors | recruiting | Phase 1 | 30 | MabQuest SAINDUSTRY | 1 | Jul 23, 2024 | clinicaltrials |
| NCT06508216 | A Study to Explore Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of Novel Therapeutics in Patients With Early Relapsed Metastatic Triple-negative Breast Cancer(COMPASS-TNBC) | recruiting | Phase 1 / Phase 2 | 50 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Jul 22, 2024 | clinicaltrials |
| NCT06274268 | Effect of Sarcopenia on the Occurrence of Toxicity Related to Anti-cancer Treatments(SARC-ONCO) | recruiting | N/A | 700 | Centre Hospitalier Metropole SavoieOTHER | 1 | Jul 18, 2024 | clinicaltrials |
| NCT05855811 | PREventing Second Cancers With DOSTARlimab(PREDOSTAR) | recruiting | Phase 2 | 400 | Centre Leon BerardOTHER | 1 | Jul 15, 2024 | clinicaltrials |
| NCT03562052 | Lung Cancer Screening in a Population Exposed to Occupational Lung Carcinogens(LUCSO) | recruiting | — | 6,000 | Centre Hospitalier Intercommunal CreteilOTHER | 1 | Jul 9, 2024 | clinicaltrials |
| NCT06490029 | Diagnostic of Various Ototoxicity Induced by Cancer Treatment(BIO-OTOTOX) | recruiting | — | 540 | Direction Centrale du Service de Santé des ArméesOTHER | 1 | Jul 8, 2024 | clinicaltrials |
| NCT05772559 | Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in Children, Teenagers and Young Adults: Molecular Profiling, Multidrug Testing and MSC Interaction Studies(ALARM3) | recruiting | — | 500 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jun 26, 2024 | clinicaltrials |
| NCT06475469 | Description of the Immune Deficiency in Patients With Untreated Chronic Lymphocytic Leukemia and Search for Predictive Factors of Infectious Risk | recruiting | N/A | 75 | CHU de ReimsOTHER | 1 | Jun 26, 2024 | clinicaltrials |
| NCT04340986 | Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma(CHC/CC) | recruiting | — | 1,250 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jun 20, 2024 | clinicaltrials |
| NCT06462664 | Exploring the Impact of Monocytes in Myeloproliferative Neoplasia (EMYNEM)(EMYNEM) | recruiting | — | 10 | University Hospital, BrestOTHER | 1 | Jun 17, 2024 | clinicaltrials |
| NCT03832127 | Evaluation of PET 18F-Fludarabine for the Initial Assessment and End-treatment of Symptomatic Multiple Myeloma Patients(Myelofludate) | recruiting | Phase 1 | 35 | Nantes University HospitalOTHER | 1 | Jun 14, 2024 | clinicaltrials |
| NCT05649683 | Immunological Functionnal Test Validation to Predict Melanoma Metastatic Patient Response to Checkpoint Inhibitors(mela-quantif) | recruiting | N/A | 60 | Centre Hospitalier Universitaire de NiceOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT03604627 | Study of Coronary Calcium Score as a Marker of Post-radiation Vascular Dysplasia in Adults Treated During Childhood for Cancer With Mediastinal Irradiation(COROCAN) | recruiting | N/A | 500 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | May 29, 2024 | clinicaltrials |
| NCT05310591 | Combination of an Anti-PD1 Antibody With Tisagenlecleucel Reinfusion in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia After Loss of Persistence(CAPTiRALL) | recruiting | Phase 1 / Phase 2 | 26 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | May 29, 2024 | clinicaltrials |
| NCT05326919 | The Patient Cohort of the National Center for Precision Medicine in Leukemia(eTHEMA) | recruiting | — | 3,000 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | May 29, 2024 | clinicaltrials |
| NCT05580861 | Sulfasalazine in AML Treated by Intensive Chemotherapy: Elderly Patients-first Line Treatment(SALMA) | recruiting | Phase 1 / Phase 2 | 64 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | May 29, 2024 | clinicaltrials |
| NCT06225128 | Dynamics of Resistance Emergence to Azacitidine-based Therapies in Acute Myeloid Leukemia(DREAM) | recruiting | — | 120 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | May 29, 2024 | clinicaltrials |
| NCT04625907 | FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma(FaR-RMS) | recruiting | Phase 1 / Phase 2 | 1,672 | University of BirminghamOTHER | 20 | May 23, 2024 | clinicaltrials |
| NCT06216496 | Evaluation of Amino Acid Metabolism Changes in Ovarian Cancer(AMINOCANCER) | recruiting | N/A | 23 | University Hospital, GrenobleOTHER | 1 | May 20, 2024 | clinicaltrials |
| NCT05525338 | Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib Bloodlevels(ADAPT ALEC) | recruiting | Phase 4 | 196 | University Medical Center GroningenOTHER | 2 | May 13, 2024 | clinicaltrials |
| NCT05345587 | Quality of Life and Economic Repercussions of Combining Proactive Medication Assessment and Electronic Monitoring of Toxicities in Subjects Undergoing Oral Cancer Therapy(PROLIFE) | recruiting | N/A | 196 | Centre Hospitalier Universitaire de NīmesOTHER | 1 | Apr 26, 2024 | clinicaltrials |
| NCT06387017 | Prospective Multicenter Cohort Study to Validate Four Groups of Biomarkers for Assessing Lung Cancer Risk Among Patients With Atheromatous Cardiovascular Disease in a Screening Pathway(BIOCEPTION) | recruiting | N/A | 750 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Apr 26, 2024 | clinicaltrials |
| NCT03767075 | A Modular Multi-Basket Trial to Improve Personalized Medicine in Cancer Patients (Basket of Baskets)(BoB) | recruiting | Phase 2 | 1,000 | Vall d'Hebron Institute of OncologyOTHER | 7 | Apr 25, 2024 | clinicaltrials |
| NCT04793919 | Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia | recruiting | Phase 2 | 89 | Associazione Italiana Ematologia Oncologia PediatricaOTHER | 12 | Apr 15, 2024 | clinicaltrials |
| NCT05704920 | Integrating Artificial Intelligence Into Lung Cancer Screening.(DACAPO) | recruiting | N/A | 2,722 | Centre Hospitalier Universitaire de NiceOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT05800132 | Diagnostic Performance of Breast Cancer Screening Second Reading Process Assisted by AI(IMA-L2) | recruiting | N/A | 5,000 | TherapixelINDUSTRY | 1 | Apr 12, 2024 | clinicaltrials |
| NCT05963061 | Chronic Myeloid Leukemia (CML) Real-Life Database | recruiting | — | 3,500 | University Hospital, Clermont-FerrandOTHER | 1 | Apr 9, 2024 | clinicaltrials |
| NCT04128072 | Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell Lymphoma(MOGAT) | recruiting | Phase 2 | 43 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Apr 5, 2024 | clinicaltrials |
| NCT05280314 | Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors | recruiting | Phase 2 | 60 | IO BiotechINDUSTRY | 6 | Mar 18, 2024 | clinicaltrials |
| NCT05116475 | Evaluation of dAroLutamide Addition to anDrogen Deprivation Therapy and radIatioN Therapy in Newly Diagnosed Prostate Cancer With Pelvic Lymph Nodes Metastases(ALADDIN) | recruiting | Phase 3 | 152 | Association Pour La Recherche des Thérapeutiques Innovantes en CancérologieOTHER | 1 | Mar 12, 2024 | clinicaltrials |
| NCT06053099 | A Prospective Cohort Study to Evaluate Molecular pRognostic Factors and Resistance Mechanisms to Osimertinib in Adjuvant Treatment of Completely Resected pIB-IIIA Non-small Cell Lung Carcinoma With Common EGFR Mutations (L858R and Del19)(ROSIE) | recruiting | N/A | 300 | Intergroupe Francophone de Cancerologie ThoraciqueOTHER | 1 | Mar 8, 2024 | clinicaltrials |
| NCT00330447 | Effects of Oncological Treatment During Pregnancy on Mother and Child | recruiting | — | 5,000 | University Hospital, GasthuisbergOTHER | 20 | Mar 6, 2024 | clinicaltrials |
| NCT04396223 | Avelumab and Methotrexate in in Low-risk Gestational Trophoblastic Neoplasias as First Line Treatment(TROPHAMET) | recruiting | Phase 1 / Phase 2 | 26 | Hospices Civils de LyonOTHER | 1 | Feb 29, 2024 | clinicaltrials |
| NCT06041555 | MRI Guided Radiotherapy and Radiobiological Data: the ISRAR Database (Irm Sequences for Radiobiological Adaptative Radiotherapy)(ISRAR) | recruiting | — | 600 | Hospices Civils de LyonOTHER | 1 | Feb 20, 2024 | clinicaltrials |
| NCT06154668 | Profiling of Circulating Immune Cells to Uncover Response Signatures to Anti-PD1 Immunotherapy in Melanoma Patients(PHENOMENAL) | recruiting | — | 707 | University Hospital, GrenobleOTHER | 1 | Feb 20, 2024 | clinicaltrials |
| NCT05988814 | Trial Evaluating the Efficacy and the Safety of FOLFIRINOX3 Treatment in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer in First Line of Chemotherapy(FOLFIRINOX3 P) | recruiting | Phase 2 | 90 | Centre Georges Francois LeclercOTHER | 1 | Feb 12, 2024 | clinicaltrials |
| NCT05199376 | Evaluation of Percutaneous Cryotherapy in the Treatment of Plexiform Neurofibromas and Unresectable Neurofibromas in Neurofibromatosis Type 1(CryoNF1) | recruiting | N/A | 30 | Centre Leon BerardOTHER | 1 | Feb 9, 2024 | clinicaltrials |
| NCT05912075 | Preoperative Radiotherapy And ASTX660 in Rectum Cancer(PRAAR1) | recruiting | Phase 1 | 78 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Feb 8, 2024 | clinicaltrials |
| NCT03838042 | INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies | recruiting | Phase 1 / Phase 2 | 91 | University Hospital HeidelbergOTHER | 7 | Feb 7, 2024 | clinicaltrials |
| NCT04253015 | A Post-Authorisation Safety Study Patient Registry of Patients With Neuroblastoma Being Treated With Dinutuximab Beta | recruiting | — | 125 | RECORDATI GROUPINDUSTRY | 7 | Feb 7, 2024 | clinicaltrials |
| NCT05794048 | METabolic PROFILE of Hepatocarcinoma and Pancreatic Tumors(PROMETHEP) | recruiting | N/A | 300 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Feb 7, 2024 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials